Veno Venous ECMO for Covid 19

Veno-Venous ECMO (VV ECMO) has been an important therapeutic option for severe respiratory failure in patients with COVID-19, particularly in cases where conventional mechanical ventilation and prone positioning fail to maintain adequate oxygenation. VV ECMO provides extracorporeal respiratory support, allowing time for the lungs to heal while bypassing the damaged respiratory system. This is particularly critical for COVID-19 patients with severe acute respiratory distress syndrome (ARDS), which can result from the viral infection causing widespread lung inflammation and significant hypoxemia (low blood oxygen levels).Why VV ECMO for COVID-19?COVID-19 infection, caused by the SARS-CoV-2 virus, can lead to severe ARDS in

Veno Venous ECMO for Interstitial Lung Disease

Veno-Venous ECMO (VV ECMO) is a form of extracorporeal membrane oxygenation used for patients with severe respiratory failure. It provides temporary respiratory support by oxygenating blood and removing carbon dioxide, bypassing the lungs. VV ECMO is particularly useful in patients with severe acute respiratory distress syndrome (ARDS), and it is also utilized in certain cases of interstitial lung disease (ILD) when conventional treatment fails to restore adequate oxygenation or ventilation.Veno-Venous ECMO for Interstitial Lung Disease (ILD)Interstitial lung disease (ILD) refers to a group of lung disorders characterized by inflammation and scarring (fibrosis) of the interstitial tissue (the tissue and space

Veno Venous ECMO for Post Transplant

Veno-Venous ECMO (VV ECMO) can be utilized as a life-saving intervention for patients who have undergone lung transplantation and are experiencing severe respiratory failure post-transplant. Lung transplant recipients are at high risk for complications that can lead to respiratory failure, including primary graft dysfunction (PGD), infection, rejection, and other complications related to the transplant process. In such cases, VV ECMO can provide temporary support to facilitate recovery or to bridge the patient to further interventions, including re-transplantation or long-term recovery.Indications for VV ECMO Post-Lung TransplantVV ECMO post-lung transplant is typically considered when the patient experiences severe respiratory failure that is

Veno Veno Arterial ECMO for Post Transplant

Veno-Veno-Arterial ECMO (VVA ECMO), also known as Veno-venous and Arterial ECMO, combines the principles of both veno-venous (VV ECMO) and veno-arterial (VA ECMO) to provide cardiopulmonary support. This hybrid ECMO modality is used in post-transplant patients who experience both respiratory and circulatory failure, or those with severe cardiac and respiratory dysfunction simultaneously. It is a more complex form of ECMO, typically used for patients who are critically ill following lung transplantation and experiencing complications such as primary graft dysfunction (PGD), severe right heart failure, or multisystem organ failure.Indications for VVA ECMO Post-Lung TransplantVVA ECMO may be required for post-lung transplant